Skip to main content

Table 1 Pathogenic/Likely pathogenic rates by clinical annotation and family structure among the 371 DD/ID-affected individuals

From: Genomic diagnosis for children with intellectual disability and/or developmental delay

Characteristic

Individuals (n (%))

Individuals with P/LP result (n (%))

Age (years)

 2–5

96 (25.8)

26/96 (27.1)

 6–12

165 (44.5)

42/165 (25.4)

 13–18

61 (16.5)

20/61 (32.8)

 19–40

47 (12.7)

15/47 (32.0)

  > 40

2 (0.54)

0/2 (0.00)

Average age (range) (years)

10.56 (2–54)

Sex

 Male

214 (57.7)

52/214 (24.3)

 Female

157 (42.3)

51/157 (32.5)

Clinical specifics

 Intellectual disability, mild (HP:0001256)

2 (0.5)

0/2 (0)

 Intellectual disability, moderate (HP:0002342)

298 (80.3)

82/298 (27.5)

 Intellectual disability, severe (HP:0010864)

44 (11.9)

11/44 (25)

 Speech delay (HP:0000750)

255 (68.7)

69/255 (27.1)

 Seizures (HP:0001250)

168 (45.3)

52/168 (30.9)

 Facial dysmorphism (HP:0001999)

112 (30.2)

33/112 (29.5)

 Autism spectrum disorder (HP:000729)

95 (25.6)

18/95 (18.9)

 Hypotonia (HP:0001252)

75 (20.2)

26/75 (34.6)

 Positive brain MRI

65 (17.5)

18/64 (28.1)

 Macrocephaly (HP:0000256)

36 (9.70)

9/36 (25.0)

 Microcephaly (HP:0000252)

34 (9.16)

16/34 (47.0)

 ADHD (HP:0007018)

27 (7.28)

7/27 (25.9)

 Failure to thrive (HP:0001508)

22 (5.90)

6/22 (27.3)

 Short stature (HP:0004322)

18 (4.85)

8/18 (44.4)

Previous genetic testing

 Microarray

222 (59.8)

61/222 (27.5)

 Single gene/Gene panel

142 (38.3)

43/142 (30.3)

 Karyotype

108 (29.1)

39/108 (36.1)

 Fragile-X

101 (27.2)

28/101 (27.7)

 Mito DNA Screen

28 (7.55)

7/28 (25.0)

Family structure

 Trio

309 (83.3)

90/309 (29.1)

 Duo

42 (11.3)

8/42 (19.0)

 Singleton

20 (5.4)

3/20 (15.0)